Business IdeasGlenmark raises Rs 413 cr in QIP
Glenmark Pharmaceuticals has raised Rs 413 crore through its recently concluded Qualified Institutional Placement (QIP), which will be used towards its debt reduction plan, a top company official said.
- Gammon India to raise Rs 958.6 crore in QIP - Sesa Goa to raise up to Rs 6,000 crore - Gammon India to raise Rs 958.6 cr via QIP - Glenmark Pharma raises Rs 413 cr through QIP - Unity Infraprojects gets shareholder nod for raising Rs 250 cr - Sesa Goa to raise Rs 6,000 cr for capex, acquisitions
“Our recently concluded QIP generated a good response from investors. The proceeds to the tune of Rs 413 crore will go towards debt reduction. Overall, we expect strong performance out of both the speciality and generic business domains in the financial year 09-10,” Glenmark Pharma’s Managing Director and CEO Glenn Saldanha told shareholders at the company’s annual general meeting.